Ensysce Biosciences (ENSCW) Return on Assets (2018 - 2025)
Ensysce Biosciences (ENSCW) reported Return on Assets of 0.01% for Q4 2025, little changed year-over-year from 0.01% in Q4 2024, and up 44.33% quarter-over-quarter from 0.03% in Q3 2025.
Ensysce Biosciences (ENSCW) Return on Assets (2018 - 2025) Analysis & Trends
Ensysce Biosciences (ENSCW) has 8 years of Return on Assets data on file, last reported at 0.01% in Q4 2025.
- Return on Assets for Q4 2025 came in at 0.01%, changed 0.0% year-over-year; the trailing twelve-month figure through Dec 2025 was 0.01% (changed 0.0% YoY), and the FY2024 annual result was 0.02%, up 1.0% from the prior year.
- Return on Assets rose to 0.01% in Q4 2025 per ENSCW's latest filing, from 0.03% in the prior quarter.
- Over five years, Return on Assets peaked at 0.0% in Q2 2021 and troughed at 0.04% in Q1 2023.
- A 5-year average of 0.02% and a median of 0.02% in 2021 frame the typical range for Return on Assets.
- The sharpest annual moves came in 2022 and 2024: Return on Assets declined 3 bps in 2022, then grew 3 bps in 2024.
- A 5-year view of Return on Assets shows it stood at 0.02% in 2021, then plunged by 104 bps to 0.03% in 2022, then retreated by 9 bps to 0.04% in 2023, then soared by 71 bps to 0.01% in 2024, then sank by 31 bps to 0.01% in 2025.
- Business Quant data shows ENSCW's Return on Assets at 0.01% in Q4 2025, 0.03% in Q3 2025, and 0.01% in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -0.80% |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -0.01% |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 0.00% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 0.00% |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -0.01% |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 0.00% |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 0.00% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -0.01% |
| 10 | Ensysce Biosciences | - | - | - | -0.01% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -0.01% |
| Sep 30, 2025 | -0.03% |
| Jun 30, 2025 | -0.01% |
| Mar 31, 2025 | -0.01% |
| Dec 31, 2024 | -0.01% |
| Sep 30, 2024 | -0.01% |
| Jun 30, 2024 | -0.03% |
| Mar 31, 2024 | -0.03% |
| Dec 31, 2023 | -0.04% |
| Sep 30, 2023 | -0.03% |
| Jun 30, 2023 | -0.03% |
| Mar 31, 2023 | -0.04% |
| Dec 31, 2022 | -0.03% |
| Sep 30, 2022 | -0.02% |
| Jun 30, 2022 | -0.03% |
| Mar 31, 2022 | -0.02% |
| Dec 31, 2021 | -0.02% |
| Sep 30, 2021 | -0.02% |
| Jun 30, 2021 | 0.00% |
| Mar 31, 2021 | -0.01% |